Bird & Bird's International Life Sciences Group would like to invite you and your colleagues to a forum to be held in Geneva, Switzerland, which is an international hub for the life sciences sector.
Legal input is crucial at the earliest stages in strategic planning and is fundamental to succeeding in this competitive, extremely challenging, and potentially lucrative market. Given the high cost and risk inherent in biotech drug development it is imperative to consider the legal and regulatory aspects in order to ensure success. Our team have a successful track record and in this seminar they will cover issues relating to advanced therapies and biosimilar drug development and regulation, and then finally look at effective technology licensing that ensures the broadest market access for your products.
The seminar will be beneficial for general and in-house counsel, life cycle management professionals and strategic planners, professionals involved in clinical development and product regulation and medical directors.
The panel will be made up of the group's leading experts from France, Belgium and the United Kingdom.
This seminar will be held in the picturesque location of the Société Nautique de Genève and drinks will follow overlooking Lake Geneva.
We hope you will be able to join us.
For further information, or to register to attend this seminar please contact Karla Fryer at karla.fryer@twobirds.com or call +44 (0)20 7415 6000.
The programme
16.15 - 16.30
Coffee and registration
16.30 - 16.35
Welcome and introduction
16.35 - 17.50
Presentations
- Biosimilars an update on developments in the US and in the EU: Prospects for global developments? Liz Fuller
- Medical applications and scientific research with human cells and tissues: Introduction to the EU regulatory framework. Marc Martens
- Licensing issues in the pharma and biotech industry. Sally Shorthose
17.50 - 18.00
Conclusion
18.00 - 20.00
Canapés and drinks